Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

BACKGROUND: Cetuximab, a chimeric mouse–human IgG1 monoclonal antibody against the epidermal growth factor receptor, is approved for use in colorectal cancer and squamous-cell carcinoma of the head and neck. A high prevalence of hypersensitivity reactions to cetuximab has been reported in some areas...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chung, Christine H., Mirakhur, Beloo, Chan, Emily, Le, Quynh-Thu, Berlin, Jordan, Morse, Michael, Murphy, Barbara A., Satinover, Shama M., Hosen, Jacob, Mauro, David, Slebos, Robbert J., Zhou, Qinwei, Gold, Diane, Hatley, Tina, Hicklin, Daniel J., Platts-Mills, Thomas A.E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2008
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361129/
https://ncbi.nlm.nih.gov/pubmed/18337601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa074943
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia